US › Healthcare

Nyxoah (NYXH)

US · Healthcare · Medical Devices

$1.11-6.72%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$7.7M

Revenue YoY

+472.8%

Net profit

$-33.0M

EPS

$-0.67

EPS estimate

$-0.47

Net margin

-429.5%

EPS came in at -0.67 against a street estimate of -0.47 — a miss of 42.6%.

Key statistics

Market cap

$133.4M

Forward P/E

0.0

P/B

1.42

Book value

$0.94

EPS (TTM)

$-2.63

52-week high

$6.20

52-week low

$1.26

50-day MA

$1.50

200-day MA

$2.77

Beta

1.00

Analyst view

Analysts rate Nyxoah a buy (2 buy, 2 hold, 0 sell out of 4) with an average price target of $4.19.

Shareholding

Insiders

33.19%

Institutions

30.87%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Nyxoah — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.